Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.
about
The stomach in health and diseaseRisk factors for neoplastic progression in Barrett's esophagusThe human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases?Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity?Alcoholic liver disease: the gut microbiome and liver cross talkCough reflex sensitization from esophagus and nose.Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?Ablation of Barrett's epithelium: the promise and the problems.Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment.Use of ranitidine is associated with infections in newborns hospitalized in a neonatal intensive care unit: a cohort studyWhole-Blood Taurine Concentrations in Cats With Intestinal Disease.In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.Adverse effects of long-term proton pump inhibitor therapy.Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?Barrett's esophagus and the increasing role of endoluminal therapy.Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors.The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesisThe relationship between obesity and functional gastrointestinal disorders: causation, association, or neither?Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors.Reflux disease management strategy: initial therapy.Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.An assessment of human gastric fluid composition as a function of PPI usageExpression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.Common Mechanism of Pathogenesis in Gastrointestinal Diseases Implied by Consistent Efficacy of Single Chinese Medicine Formula: A PRISMA-Compliant Systematic Review and Meta-AnalysisAn Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis.Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.Gastric juice: a barrier against infectious diseases.Mechanisms of disease: Carcinogenesis in Barrett's esophagus.Community-acquired pneumonia and acid-suppressive drugs: position statementBile acids and Barrett's oesophagus: a sine qua non or coincidence?Barrett esophagus: what a mouse model can teach us about human diseaseGut Microbiome: What We Do and Don't Know.From Reflux Esophagitis to Esophageal Adenocarcinoma.Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.Surgery for gastroesophageal reflux disease: esophageal impedance to progress?Use of proton pump inhibitors and subsequent risk of celiac disease
P2860
Q26784036-D2A2F4DA-A40E-4D65-8579-0B2CECF20B94Q27002062-42C885D4-C5EB-4882-A89E-57703A50A5A2Q27004050-FA9A5663-6842-4C7A-96E8-F6D5316AAD0EQ27024567-8B5F1887-EEB3-4F80-ACCA-B3327059ACB1Q27025627-D06087DB-5DDA-4804-A12F-53D79512D5C3Q28080617-77A91589-316A-455E-8075-F70FD82342FFQ28346256-F5C7A88F-5609-47DE-92DA-46F8A327C8F6Q31075885-703C5E88-F44D-406D-B4F3-A4A8B167EF92Q33648565-B2541C64-2B2A-4379-8C15-76128765661EQ33742768-4B74BD3C-1C3E-4105-83AC-EC15E5E8F5D0Q33900117-7ADBE1F6-2B5A-4D54-967D-6E910452DBB8Q33913295-F24B2AF1-8BD4-4217-B7C6-5885D3160C3DQ34167899-867869A8-FDD7-4C81-B151-B18F46C4A4BFQ34170707-B3CAC210-5BD4-40D4-9D00-D55D0C6F166DQ34408906-DD33E5D5-8FE0-4060-A212-8900FEE3EB2CQ34510524-E273429A-7250-4815-9324-94ED9D443D99Q34566765-F74A3B61-9F4D-4996-8B83-83F20522EEA4Q34573211-7C909851-AA6B-4739-ABE2-8646C82D486AQ34959399-34CF7155-A11D-4645-9291-42422DD91490Q34985967-55CD80A1-F933-4526-980F-80DB3CF045ECQ35013649-2C0214CC-5A17-4046-87B1-E35462D1E04EQ35076651-E72CF52D-66EE-4DCA-8613-DD71C1AA88DCQ35159625-04EF4D37-6145-4B6A-8420-B502E5C7579EQ35210012-AC6D8E04-4C41-41E0-AE79-9F1171F0D0D5Q35294176-512A7591-CD79-4FA1-8E51-C8741EB5EEF9Q35670419-1B2F0EEB-CF73-444C-8A9A-AE56735B2673Q35857980-D3D2A69F-F4D9-44EA-A3FF-0E7247CED764Q35917169-7F1CEFB0-B102-4244-942B-FC299F84F184Q35922573-C14FCAA7-65FE-49AB-A1E2-DEF1E6413B19Q35953908-4B39AAB5-FFF3-40BA-B805-D8DAE9BD3A4AQ36023592-EE270EFE-C864-4A1D-A6D1-1A0D8C99655CQ36304065-F75E8F2A-86EC-4FDA-BF4E-1B88062ABE88Q36398145-BB9C5D55-52F2-4C5A-A578-BBA1EDA4E829Q36510659-AFD71240-CFF0-49AB-9691-C812C2CD082AQ36556299-5DEFBCD9-52D6-4B87-AA60-AA583FB08AB5Q36816915-FC6C725E-34FE-462C-8EB2-DCFA2DD2CA2EQ37074161-4059D67C-D05D-46D9-A7F9-E586B0D43A10Q37279832-A269DF5C-69D3-49B8-B871-E185C530F684Q37463531-F7C7F54B-87F4-44E1-8A9C-1DE00185550CQ37625863-4A130112-CF53-4369-AE98-1D307E6E8AE2
P2860
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Suppression of gastric acid se ...... d deconjugation of bile acids.
@en
type
label
Suppression of gastric acid se ...... d deconjugation of bile acids.
@en
prefLabel
Suppression of gastric acid se ...... d deconjugation of bile acids.
@en
P2093
P1476
Suppression of gastric acid se ...... d deconjugation of bile acids.
@en
P2093
Bremner CG
Crookes PF
DeMeester SR
DeMeester TR
Johansson J
P356
10.1016/S1091-255X(00)80032-3
P577
2000-01-01T00:00:00Z
P5875
P6179
1028928054